Global Motion Sickness Pills Market Research Report 2023

Motion Sickness Pills Market

Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Motion Sickness Pills market research.

The motion sickness pills market is driven by several factors. One of the primary drivers is the increasing prevalence of motion sickness among individuals traveling by various modes of transportation, such as cars, planes, trains, and boats. Motion sickness, characterized by symptoms like nausea, dizziness, and vomiting, affects a significant portion of the population, leading to a rising demand for effective treatment options. Additionally, the growing tourism and travel industry, coupled with the increasing popularity of adventure and recreational activities, have expanded the potential consumer base for motion sickness pills. The convenience and ease of use offered by these pills, providing quick relief from symptoms, further contribute to their market growth. Moreover, advancements in drug formulations, such as non-drowsy and long-lasting options, have improved patient compliance and satisfaction. Additionally, the availability of over-the-counter options and increased accessibility of these medications in pharmacies and online platforms have further fueled the demand for motion sickness pills. Overall, the motion sickness pills market is driven by the increasing prevalence of motion sickness, expanding travel industry, advancements in drug formulations, and improved accessibility to these medications.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Motion Sickness Pills market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Motion Sickness Pills Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Motion Sickness Pills Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Anticholinergic

1.2.3 Antihistamines

1.2.4 Others

1.3 Market by Application

1.3.1 Global Motion Sickness Pills Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Adults

1.3.3 Children

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Motion Sickness Pills Market Perspective (2018-2029)

2.2 Motion Sickness Pills Growth Trends by Region

2.2.1 Global Motion Sickness Pills Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Motion Sickness Pills Historic Market Size by Region (2018-2023)

2.2.3 Motion Sickness Pills Forecasted Market Size by Region (2024-2029)

2.3 Motion Sickness Pills Market Dynamics

2.3.1 Motion Sickness Pills Industry Trends

2.3.2 Motion Sickness Pills Market Drivers

2.3.3 Motion Sickness Pills Market Challenges

2.3.4 Motion Sickness Pills Market Restraints

3.1 Global Top Motion Sickness Pills Players by Revenue

3.1.1 Global Top Motion Sickness Pills Players by Revenue (2018-2023)

3.1.2 Global Motion Sickness Pills Revenue Market Share by Players (2018-2023)

3.2 Global Motion Sickness Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Motion Sickness Pills Revenue

3.4 Global Motion Sickness Pills Market Concentration Ratio

3.4.1 Global Motion Sickness Pills Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Motion Sickness Pills Revenue in 2022

3.5 Motion Sickness Pills Key Players Head office and Area Served

3.6 Key Players Motion Sickness Pills Product Solution and Service

3.7 Date of Enter into Motion Sickness Pills Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Motion Sickness Pills Historic Market Size by Type (2018-2023)

4.2 Global Motion Sickness Pills Forecasted Market Size by Type (2024-2029)

5.1 Global Motion Sickness Pills Historic Market Size by Application (2018-2023)

5.2 Global Motion Sickness Pills Forecasted Market Size by Application (2024-2029)

6.1 North America Motion Sickness Pills Market Size (2018-2029)

6.2 North America Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Motion Sickness Pills Market Size by Country (2018-2023)

6.4 North America Motion Sickness Pills Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Motion Sickness Pills Market Size (2018-2029)

7.2 Europe Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Motion Sickness Pills Market Size by Country (2018-2023)

7.4 Europe Motion Sickness Pills Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Motion Sickness Pills Market Size (2018-2029)

8.2 Asia-Pacific Motion Sickness Pills Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Motion Sickness Pills Market Size by Region (2018-2023)

8.4 Asia-Pacific Motion Sickness Pills Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Motion Sickness Pills Market Size (2018-2029)

9.2 Latin America Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Motion Sickness Pills Market Size by Country (2018-2023)

9.4 Latin America Motion Sickness Pills Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Motion Sickness Pills Market Size (2018-2029)

10.2 Middle East & Africa Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Motion Sickness Pills Market Size by Country (2018-2023)

10.4 Middle East & Africa Motion Sickness Pills Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Motion Sickness Pills Introduction

11.1.4 GlaxoSmithKline Revenue in Motion Sickness Pills Business (2018-2023)

11.1.5 GlaxoSmithKline Recent Development

11.2 Prestige Brands

11.2.1 Prestige Brands Company Detail

11.2.2 Prestige Brands Business Overview

11.2.3 Prestige Brands Motion Sickness Pills Introduction

11.2.4 Prestige Brands Revenue in Motion Sickness Pills Business (2018-2023)

11.2.5 Prestige Brands Recent Development

11.3 WellSpring Pharmaceutical Corporation

11.3.1 WellSpring Pharmaceutical Corporation Company Detail

11.3.2 WellSpring Pharmaceutical Corporation Business Overview

11.3.3 WellSpring Pharmaceutical Corporation Motion Sickness Pills Introduction

11.3.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Pills Business (2018-2023)

11.3.5 WellSpring Pharmaceutical Corporation Recent Development

11.4 Baxter International

11.4.1 Baxter International Company Detail

11.4.2 Baxter International Business Overview

11.4.3 Baxter International Motion Sickness Pills Introduction

11.4.4 Baxter International Revenue in Motion Sickness Pills Business (2018-2023)

11.4.5 Baxter International Recent Development

11.5 Vartaris

11.5.1 Vartaris Company Detail

11.5.2 Vartaris Business Overview

11.5.3 Vartaris Motion Sickness Pills Introduction

11.5.4 Vartaris Revenue in Motion Sickness Pills Business (2018-2023)

11.5.5 Vartaris Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Motion Sickness Pills Introduction

11.6.4 Novartis Revenue in Motion Sickness Pills Business (2018-2023)

11.6.5 Novartis Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Motion Sickness Pills Introduction

11.7.4 Pfizer Revenue in Motion Sickness Pills Business (2018-2023)

11.7.5 Pfizer Recent Development

11.8 Myungmoon Pharm

11.8.1 Myungmoon Pharm Company Detail

11.8.2 Myungmoon Pharm Business Overview

11.8.3 Myungmoon Pharm Motion Sickness Pills Introduction

11.8.4 Myungmoon Pharm Revenue in Motion Sickness Pills Business (2018-2023)

11.8.5 Myungmoon Pharm Recent Development

11.9 Caleb Pharmaceuticals

11.9.1 Caleb Pharmaceuticals Company Detail

11.9.2 Caleb Pharmaceuticals Business Overview

11.9.3 Caleb Pharmaceuticals Motion Sickness Pills Introduction

11.9.4 Caleb Pharmaceuticals Revenue in Motion Sickness Pills Business (2018-2023)

11.9.5 Caleb Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Motion Sickness Pills Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Anticholinergic

    Table 3. Key Players of Antihistamines

    Table 4. Key Players of Others

    Table 5. Global Motion Sickness Pills Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Motion Sickness Pills Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Motion Sickness Pills Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Motion Sickness Pills Market Share by Region (2018-2023)

    Table 9. Global Motion Sickness Pills Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Motion Sickness Pills Market Share by Region (2024-2029)

    Table 11. Motion Sickness Pills Market Trends

    Table 12. Motion Sickness Pills Market Drivers

    Table 13. Motion Sickness Pills Market Challenges

    Table 14. Motion Sickness Pills Market Restraints

    Table 15. Global Motion Sickness Pills Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Motion Sickness Pills Market Share by Players (2018-2023)

    Table 17. Global Top Motion Sickness Pills Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Pills as of 2022)

    Table 18. Ranking of Global Top Motion Sickness Pills Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Motion Sickness Pills Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Motion Sickness Pills Product Solution and Service

    Table 22. Date of Enter into Motion Sickness Pills Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Motion Sickness Pills Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Motion Sickness Pills Revenue Market Share by Type (2018-2023)

    Table 26. Global Motion Sickness Pills Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Motion Sickness Pills Revenue Market Share by Type (2024-2029)

    Table 28. Global Motion Sickness Pills Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Motion Sickness Pills Revenue Market Share by Application (2018-2023)

    Table 30. Global Motion Sickness Pills Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Motion Sickness Pills Revenue Market Share by Application (2024-2029)

    Table 32. North America Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Motion Sickness Pills Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Motion Sickness Pills Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Motion Sickness Pills Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Motion Sickness Pills Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Motion Sickness Pills Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Motion Sickness Pills Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Motion Sickness Pills Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Motion Sickness Pills Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Motion Sickness Pills Market Size by Country (2024-2029) & (US$ Million)

    Table 47. GlaxoSmithKline Company Detail

    Table 48. GlaxoSmithKline Business Overview

    Table 49. GlaxoSmithKline Motion Sickness Pills Product

    Table 50. GlaxoSmithKline Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 51. GlaxoSmithKline Recent Development

    Table 52. Prestige Brands Company Detail

    Table 53. Prestige Brands Business Overview

    Table 54. Prestige Brands Motion Sickness Pills Product

    Table 55. Prestige Brands Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 56. Prestige Brands Recent Development

    Table 57. WellSpring Pharmaceutical Corporation Company Detail

    Table 58. WellSpring Pharmaceutical Corporation Business Overview

    Table 59. WellSpring Pharmaceutical Corporation Motion Sickness Pills Product

    Table 60. WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 61. WellSpring Pharmaceutical Corporation Recent Development

    Table 62. Baxter International Company Detail

    Table 63. Baxter International Business Overview

    Table 64. Baxter International Motion Sickness Pills Product

    Table 65. Baxter International Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 66. Baxter International Recent Development

    Table 67. Vartaris Company Detail

    Table 68. Vartaris Business Overview

    Table 69. Vartaris Motion Sickness Pills Product

    Table 70. Vartaris Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 71. Vartaris Recent Development

    Table 72. Novartis Company Detail

    Table 73. Novartis Business Overview

    Table 74. Novartis Motion Sickness Pills Product

    Table 75. Novartis Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 76. Novartis Recent Development

    Table 77. Pfizer Company Detail

    Table 78. Pfizer Business Overview

    Table 79. Pfizer Motion Sickness Pills Product

    Table 80. Pfizer Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 81. Pfizer Recent Development

    Table 82. Myungmoon Pharm Company Detail

    Table 83. Myungmoon Pharm Business Overview

    Table 84. Myungmoon Pharm Motion Sickness Pills Product

    Table 85. Myungmoon Pharm Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 86. Myungmoon Pharm Recent Development

    Table 87. Caleb Pharmaceuticals Company Detail

    Table 88. Caleb Pharmaceuticals Business Overview

    Table 89. Caleb Pharmaceuticals Motion Sickness Pills Product

    Table 90. Caleb Pharmaceuticals Revenue in Motion Sickness Pills Business (2018-2023) & (US$ Million)

    Table 91. Caleb Pharmaceuticals Recent Development

    Table 92. Research Programs/Design for This Report

    Table 93. Key Data Information from Secondary Sources

    Table 94. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Motion Sickness Pills Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Motion Sickness Pills Market Share by Type: 2022 VS 2029

    Figure 3. Anticholinergic Features

    Figure 4. Antihistamines Features

    Figure 5. Others Features

    Figure 6. Global Motion Sickness Pills Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Motion Sickness Pills Market Share by Application: 2022 VS 2029

    Figure 8. Adults Case Studies

    Figure 9. Children Case Studies

    Figure 10. Motion Sickness Pills Report Years Considered

    Figure 11. Global Motion Sickness Pills Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Motion Sickness Pills Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Motion Sickness Pills Market Share by Region: 2022 VS 2029

    Figure 14. Global Motion Sickness Pills Market Share by Players in 2022

    Figure 15. Global Top Motion Sickness Pills Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Pills as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Motion Sickness Pills Revenue in 2022

    Figure 17. North America Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Motion Sickness Pills Market Share by Country (2018-2029)

    Figure 19. United States Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Motion Sickness Pills Market Share by Country (2018-2029)

    Figure 23. Germany Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Motion Sickness Pills Market Share by Region (2018-2029)

    Figure 31. China Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Motion Sickness Pills Market Share by Country (2018-2029)

    Figure 39. Mexico Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Motion Sickness Pills Market Share by Country (2018-2029)

    Figure 43. Turkey Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Motion Sickness Pills Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. GlaxoSmithKline Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 46. Prestige Brands Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 47. WellSpring Pharmaceutical Corporation Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 48. Baxter International Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 49. Vartaris Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 50. Novartis Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 51. Pfizer Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 52. Myungmoon Pharm Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 53. Caleb Pharmaceuticals Revenue Growth Rate in Motion Sickness Pills Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed